홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Dimethylformamide → HCID 22100652, 화합물

HRID 1458410
노트
인쇄 미리보기

반응식

HRID 1458410 반응식
[CH3:1][C:2]1[NH:3][C:4]2[CH:10]=[C:9]([O:11][Si:12]([C:15]([CH3:18])([CH3:17])[CH3:16])([CH3:14])[CH3:13])[C:8]([O:19][CH:20]3[CH2:25][CH2:24][N:23]([C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])[CH2:22][CH2:21]3)=[CH:7][C:5]=2[N:6]=1.[H-].[Na+].BrC[C:37]1[CH:46]=[C:45]2[C:40]([CH:41]=[CH:42][C:43](C#N)=[CH:44]2)=[CH:39][CH:38]=1.[C:49](OCC)(=O)C.[CH3:55][N:56]([CH:58]=O)C>O>[CH3:1][C:2]1[N:6]([CH2:49][C:41]2[C:40]3[C:45](=[CH:46][CH:37]=[CH:38][CH:39]=3)[C:44]([C:55]#[N:56])=[CH:43][CH:42]=2)[C:5]2[CH:7]=[C:8]([O:19][CH:20]3[CH2:21][CH2:22][N:23]([C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])[CH2:24][CH2:25]3)[C:9]([O:11][Si:12]([C:15]([CH3:18])([CH3:16])[CH3:17])([CH3:14])[CH3:13])=[CH:10][C:4]=2[N:3]=1.[CH3:1][C:2]1[N:3]([CH2:49][C:41]2[C:40]3[C:45](=[CH:46][CH:37]=[CH:38][CH:39]=3)[C:44]([C:58]#[N:56])=[CH:43][CH:42]=2)[C:4]2[CH:10]=[C:9]([O:11][Si:12]([C:15]([CH3:18])([CH3:16])[CH3:17])([CH3:14])[CH3:13])[C:8]([O:19][CH:20]3[CH2:21][CH2:22][N:23]([C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])[CH2:24][CH2:25]3)=[CH:7][C:5]=2[N:6]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 6228DimethylformamideHCID 8857Ethyl AcetateHCID 24758Sodium hydrideHCID 98377487-(Bromomethyl)-2-naphthonitrileHCID 22100646HCID 22100646, 화합물

생성물 2

HCID 22100652HCID 22100652, 화합물
HCID 22100801
HCID 22100801, 화합물

시약·촉매·용매 1

HCID 962Water용매

실험 절차

To 2-methyl-5-(tert-butyldimethylsilyl)oxy-6-(N-(tert-butoxycarbonyl)piperidin-4-yloxy)benzimidazole (6.6 g) in DMF (50 mL) was added NaH (0.65 g) at ambient temperature. After stirring at ambient temperature for 30 minutes 7-bromomethyl-2-naphthonitrile (3.88 g) was added. The reaction mixture was stirred at ambient temperature for 1 hour. The reaction was worked up between ethyl acetate and H2O. The organic layer was dried, concentrated and purified by silica gel chromatography (hexane/ethyl acetate/CH2Cl2 /methanol, gradient) to afford 2-methyl-5-(tert-butyldimethylsilyl)oxy-6-(N-(tert-butoxycarbonyl)piperidin-4-yloxy)-1-(4-cyanonaphth-1-yl)methylbenzimidazole and 2-methyl-6-(tert-butyldimethylsilyl)oxy-5-(N-(tert-butoxycarbonyl)piperidin-4-yloxy)-1-(4-cyanonaphth-1-yl)methylbenzimidazole.

후처리

  1. additionwas added
  2. customThe organic layer was dried
  3. concentrationconcentrated
  4. custompurified by silica gel chromatography (hexane/ethyl acetate/CH2Cl2 /methanol, gradient)

출처 및 근거

ORD 기록
ord-eaa836c89893413a8a9e64d460481503
출처 데이터셋
uspto-grants-1998_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05849759

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트